Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported strong financial results for Q3 2020, with total revenue reaching $180.1 million, a 15% increase from the previous year. Net income soared 137% to $25.4 million, and net income attributable to ApolloMed increased to $16.7 million. For the nine months ending September 30, 2020, total revenue was $510.4 million, marking a 34% increase year-over-year. The company raised its full-year guidance, now expecting total revenue between $665.0 million and $675.0 million, and adjusted EBITDA between $97.0 million and $112.0 million.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has announced it will release its consolidated financial results for the third quarter ended September 30, 2020, on November 4, 2020, after market close. The company focuses on integrated population health management, particularly for senior patients and those with chronic conditions, through its various subsidiaries and affiliated organizations. This release is expected to provide insights into ApolloMed's financial performance and strategic initiatives in the healthcare sector.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported a strong second quarter for 2020, with total revenue reaching $165.2 million, marking a 27% increase from the previous year. This growth was primarily driven by acquisitions contributing approximately $45 million in revenue. Capitation revenue rose 37% to $140.9 million, representing 85% of total revenue. Net income attributable to ApolloMed was $7.0 million, up from $3.5 million year-over-year. The company maintains guidance for full-year revenue between $665 million and $675 million.